$4.54 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 88 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 46.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NUVALENT INC | $918,987,373 | +9.0% | 19,991,024 | 0.0% | 20.25% | +12.5% | ||
| GLAUKOS CORPnote 2.750% 6/1 | $426,548,000 | +3.3% | 271,452,000 | 0.0% | 9.40% | +6.7% | ||
| VTRS | Buy | VIATRIS INC | $195,853,962 | +10.9% | 19,863,485 | +12.2% | 4.32% | +14.4% |
| New | INVITAE CORPdebt 4.500% 3/1 | $163,823,402 | – | 217,766,000 | +100.0% | 3.61% | – | |
| TABULA RASA HEALTHCARE INCnote 1.750% 2/1 | $141,534,635 | +18.0% | 144,516,000 | 0.0% | 3.12% | +21.7% | ||
| CNC | Buy | CENTENE CORP DEL | $137,071,200 | +50.6% | 1,990,000 | +47.5% | 3.02% | +55.5% |
| NBIX | NEUROCRINE BIOSCIENCES INC | $136,092,825 | +19.3% | 1,209,714 | 0.0% | 3.00% | +23.1% | |
| NATERA INCnote 2.250% 5/0 | $133,525,487 | -9.1% | 101,042,000 | 0.0% | 2.94% | -6.2% | ||
| AHCO | Buy | ADAPTHEALTH CORP | $123,832,254 | -8.3% | 13,607,940 | +22.7% | 2.73% | -5.4% |
| BROOKDALE SR LIVING INCnote 2.000%10/1 | $114,346,109 | -0.4% | 145,955,000 | 0.0% | 2.52% | +2.7% | ||
| Buy | ACCOLADE INCnote 0.500% 4/0 | $107,928,275 | +5.7% | 132,598,000 | +8.2% | 2.38% | +9.1% | |
| Buy | INSMED INCnote 1.750% 1/1 | $107,555,623 | +9.5% | 108,858,000 | +5.5% | 2.37% | +13.1% | |
| INTERCEPT PHARMACEUTICALS INnote 3.500% 2/1 | $105,134,820 | +11.8% | 98,354,000 | 0.0% | 2.32% | +15.3% | ||
| OMI | Buy | OWENS & MINOR INC NEW | $103,989,600 | +15.1% | 6,435,000 | +35.6% | 2.29% | +18.8% |
| CPRX | CATALYST PHARMACEUTICALS INC | $95,764,480 | -13.0% | 8,192,000 | 0.0% | 2.11% | -10.2% | |
| MRUS | Buy | MERUS N V | $91,418,198 | +14.5% | 3,876,938 | +27.9% | 2.01% | +18.2% |
| DCPH | Buy | DECIPHERA PHARMACEUTICALS IN | $87,737,548 | -7.1% | 6,897,606 | +2.8% | 1.93% | -4.1% |
| LRMR | LARIMAR THERAPEUTICS INC | $66,918,360 | +26.2% | 16,941,357 | 0.0% | 1.47% | +30.2% | |
| BIO | New | BIO RAD LABS INCcl a | $62,351,302 | – | 173,947 | +100.0% | 1.37% | – |
| IDYA | IDEAYA BIOSCIENCES INC | $61,207,583 | +14.8% | 2,268,628 | 0.0% | 1.35% | +18.5% | |
| Buy | ENHABIT INC | $56,224,643 | +1.6% | 4,997,746 | +3.9% | 1.24% | +4.9% | |
| Buy | HILLEVAX INC | $53,856,907 | -5.9% | 4,004,231 | +20.3% | 1.19% | -2.9% | |
| NANOSTRING TECHNOLOGIES INCnote 2.625% 3/0 | $53,000,791 | -3.2% | 70,204,000 | 0.0% | 1.17% | -0.1% | ||
| BKD | BROOKDALE SR LIVING INC | $52,493,755 | -1.9% | 12,679,651 | 0.0% | 1.16% | +1.3% | |
| RVMD | REVOLUTION MEDICINES INC | $48,481,409 | +3.5% | 1,751,496 | 0.0% | 1.07% | +6.8% | |
| LIVONGO HEALTH INCnote 0.875% 6/0 | $45,665,200 | +1.1% | 50,000,000 | 0.0% | 1.01% | +4.4% | ||
| IART | New | INTEGRA LIFESCIENCES HLDGS C | $43,033,523 | – | 1,126,827 | +100.0% | 0.95% | – |
| SGRY | New | SURGERY PARTNERS INC | $42,705,000 | – | 1,460,000 | +100.0% | 0.94% | – |
| SBTX | ARS PHARMACEUTICALS INC | $41,874,564 | -43.6% | 11,077,927 | 0.0% | 0.92% | -41.8% | |
| KURA | Buy | KURA ONCOLOGY INC | $39,891,281 | +16.4% | 4,374,044 | +35.1% | 0.88% | +20.2% |
| GH | Buy | GUARDANT HEALTH INC | $39,419,273 | -12.2% | 1,329,935 | +6.1% | 0.87% | -9.4% |
| ICPT | INTERCEPT PHARMACEUTICALS IN | $38,524,136 | +67.6% | 2,077,893 | 0.0% | 0.85% | +72.9% | |
| SWTX | Buy | SPRINGWORKS THERAPEUTICS INC | $36,519,751 | -11.8% | 1,579,574 | +0.0% | 0.80% | -8.9% |
| CABA | CABALETTA BIO INC | $35,616,596 | +17.9% | 2,340,118 | 0.0% | 0.78% | +21.7% | |
| CMAX | Buy | CAREMAX INC | $33,651,212 | -31.8% | 15,873,213 | +0.1% | 0.74% | -29.6% |
| STRUCTURE THERAPEUTICS INCsponsored ads | $31,654,331 | +21.3% | 627,813 | 0.0% | 0.70% | +25.1% | ||
| HEALTH CATALYST INCnote 2.500% 4/1 | $28,517,130 | -0.3% | 30,000,000 | 0.0% | 0.63% | +2.8% | ||
| New | RAYZEBIO INC | $25,732,597 | – | 1,159,126 | +100.0% | 0.57% | – | |
| Buy | DOCGO INC | $25,392,120 | -11.4% | 4,764,000 | +55.7% | 0.56% | -8.7% | |
| BCRX | Buy | BIOCRYST PHARMACEUTICALS INC | $23,264,880 | +150.0% | 3,286,000 | +148.6% | 0.51% | +157.8% |
| EWTX | EDGEWISE THERAPEUTICS INC | $22,536,875 | -26.1% | 3,933,137 | 0.0% | 0.50% | -23.7% | |
| PODD | New | INSULET CORP | $20,255,230 | – | 127,000 | +100.0% | 0.45% | – |
| DISC MEDICINE INC | $20,201,400 | +5.8% | 430,000 | 0.0% | 0.44% | +9.1% | ||
| ALHC | Buy | ALIGNMENT HEALTHCARE INC | $19,064,284 | +80.0% | 2,747,015 | +49.1% | 0.42% | +85.8% |
| Buy | ROIVANT SCIENCES LTD | $18,740,408 | +37.2% | 1,604,487 | +18.4% | 0.41% | +41.4% | |
| Sell | PTC THERAPEUTICS INCnote 1.500% 9/1 | $17,509,030 | -46.9% | 22,000,000 | -31.2% | 0.39% | -45.2% | |
| New | CARIBOU BIOSCIENCES INC | $16,730,000 | – | 3,500,000 | +100.0% | 0.37% | – | |
| CSTL | New | CASTLE BIOSCIENCES INC | $15,988,412 | – | 946,620 | +100.0% | 0.35% | – |
| DAWN | DAY ONE BIOPHARMACEUTICALS I | $15,582,802 | +2.8% | 1,269,992 | 0.0% | 0.34% | +5.9% | |
| VKTX | Buy | VIKING THERAPEUTICS INC | $14,158,530 | -22.4% | 1,279,000 | +13.7% | 0.31% | -19.8% |
| TARS | New | TARSUS PHARMACEUTICALS INC | $13,399,326 | – | 754,042 | +100.0% | 0.30% | – |
| VERASTEM INC | $12,507,688 | +9.3% | 1,538,461 | 0.0% | 0.28% | +13.1% | ||
| DNLI | DENALI THERAPEUTICS INC | $12,274,623 | -30.1% | 594,989 | 0.0% | 0.27% | -28.0% | |
| New | QUIDELORTHO CORP | $10,956,000 | – | 150,000 | +100.0% | 0.24% | – | |
| COGT | Sell | COGENT BIOSCIENCES INC | $10,621,114 | -73.4% | 1,089,345 | -67.6% | 0.23% | -72.5% |
| LUNG | Sell | PULMONX CORP | $10,515,506 | -24.6% | 1,017,958 | -4.4% | 0.23% | -22.1% |
| RVNC | REVANCE THERAPEUTICS INC | $9,978,900 | -54.7% | 870,000 | 0.0% | 0.22% | -53.2% | |
| Sell | VIGIL NEUROSCIENCE INC | $9,849,686 | -48.9% | 1,827,400 | -10.9% | 0.22% | -47.3% | |
| BCYC | New | BICYCLE THERAPEUTICS PLCsponsored ads | $9,015,448 | – | 448,753 | +100.0% | 0.20% | – |
| New | TANGO THERAPEUTICS INC | $8,937,389 | – | 793,729 | +100.0% | 0.20% | – | |
| PRIME MEDICINE INC | $8,445,896 | -34.9% | 885,314 | 0.0% | 0.19% | -32.9% | ||
| FDMT | 4D MOLECULAR THERAPEUTICS IN | $8,274,500 | -29.6% | 650,000 | 0.0% | 0.18% | -27.5% | |
| ITOS | New | ITEOS THERAPEUTICS INC | $7,916,850 | – | 723,000 | +100.0% | 0.17% | – |
| FUSN | FUSION PHARMACEUTICALS INC | $7,339,800 | -44.3% | 2,823,000 | 0.0% | 0.16% | -42.3% | |
| ALEC | ALECTOR INC | $6,837,644 | +7.8% | 1,055,192 | 0.0% | 0.15% | +11.9% | |
| NEOGENOMICS INCnote 1.250% 5/0 | $5,994,495 | -0.9% | 6,500,000 | 0.0% | 0.13% | +2.3% | ||
| THE ONCOLOGY INSTITUTE INC | $4,704,073 | +154.5% | 3,360,052 | 0.0% | 0.10% | +166.7% | ||
| GENEDX HOLDINGS CORP | $4,564,178 | -38.9% | 1,253,895 | 0.0% | 0.10% | -36.9% | ||
| FHTX | FOGHORN THERAPEUTICS INC | $3,887,625 | -29.0% | 777,525 | 0.0% | 0.09% | -26.5% | |
| Sell | NYXOAH S A | $2,821,805 | -22.6% | 400,256 | -12.1% | 0.06% | -20.5% | |
| BDTX | Sell | BLACK DIAMOND THERAPEUTICS I | $2,670,383 | -70.6% | 930,447 | -48.3% | 0.06% | -69.6% |
| ORCHARD THERAPEUTICS PLCspon ads new | $2,443,986 | +48.4% | 316,169 | 0.0% | 0.05% | +54.3% | ||
| OMIC | Sell | SINGULAR GENOMICS SYSTEMS IN | $1,899,236 | -64.5% | 4,984,871 | -22.7% | 0.04% | -63.2% |
| AFIB | ACUTUS MED INC | $1,853,519 | -21.6% | 2,660,808 | 0.0% | 0.04% | -18.0% | |
| ANNX | ANNEXON INC | $1,378,035 | -33.0% | 583,913 | 0.0% | 0.03% | -31.8% | |
| CUTR | New | CUTERA INC | $929,524 | – | 154,406 | +100.0% | 0.02% | – |
| NEWAMSTERDAM PHARMA COMPANY*w exp 11/22/202 | $176,295 | -9.1% | 92,787 | 0.0% | 0.00% | 0.0% | ||
| CMAXW | CAREMAX INC*w exp 06/08/202 | $134,400 | -48.2% | 672,000 | 0.0% | 0.00% | -50.0% | |
| THE ONCOLOGY INSTITUTE INC*w exp 11/15/202 | $114,875 | +229.4% | 1,250,000 | 0.0% | 0.00% | +200.0% | ||
| New | TRISALUS LIFE SCIENCES INC*w exp 08/10/202 | $126,667 | – | 333,333 | +100.0% | 0.00% | – | |
| QSIAW | QUANTUM SI INC*w exp 06/10/202 | $90,000 | +17.3% | 333,333 | 0.0% | 0.00% | 0.0% | |
| New | MEDAVAIL HOLDINGS INC | $100,392 | – | 16,732 | +100.0% | 0.00% | – | |
| SIENTRA INC | $27,800 | -5.1% | 10,000 | 0.0% | 0.00% | 0.0% | ||
| SOMALOGIC INC*w exp 08/31/202 | $26,412 | -12.0% | 120,000 | 0.0% | 0.00% | 0.0% | ||
| BFLYWS | BUTTERFLY NETWORK INC*w exp 02/12/202 | $48,547 | -71.9% | 733,333 | 0.0% | 0.00% | -75.0% | |
| MTACU | Exit | MEDTECH ACQUISITION CORPunit 12/18/2025 | $0 | – | -1 | -100.0% | 0.00% | – |
| New | TRISALUS LIFE SCIENCES INC | $5 | – | 1 | +100.0% | 0.00% | – | |
| SURROZEN INC*w exp 08/01/203 | $6,850 | -25.5% | 166,666 | 0.0% | 0.00% | – | ||
| NUVBWS | NUVATION BIO INC*w exp 07/07/202 | $16,667 | -39.5% | 166,666 | 0.0% | 0.00% | -100.0% | |
| MTACW | Exit | MEDTECH ACQUISITION CORP*w exp 12/22/202 | $0 | – | -333,333 | -100.0% | 0.00% | – |
| MDVL | Exit | MEDAVAIL HOLDINGS INC | $0 | – | -836,626 | -100.0% | -0.00% | – |
| Exit | CALCIMEDICA INC | $0 | – | -265,657 | -100.0% | -0.02% | – | |
| QSI | Exit | QUANTUM SI INC | $0 | – | -797,500 | -100.0% | -0.03% | – |
| ELEV | Exit | ELEVATION ONCOLOGY INC | $0 | – | -1,381,416 | -100.0% | -0.04% | – |
| Exit | ROIVANT SCIENCES LTD*w exp 09/30/202 | $0 | – | -1,000,000 | -100.0% | -0.05% | – | |
| Exit | ABEONA THERAPEUTICS INC | $0 | – | -869,565 | -100.0% | -0.08% | – | |
| PHAT | Exit | PHATHOM PHARMACEUTICALS INC | $0 | – | -656,000 | -100.0% | -0.20% | – |
| MRSN | Exit | MERSANA THERAPEUTICS INC | $0 | – | -2,885,400 | -100.0% | -0.20% | – |
| NUVB | Exit | NUVATION BIO INC | $0 | – | -5,854,860 | -100.0% | -0.22% | – |
| AXNX | Exit | AXONICS INC | $0 | – | -225,000 | -100.0% | -0.24% | – |
| ANAB | Exit | ANAPTYSBIO INC | $0 | – | -613,000 | -100.0% | -0.27% | – |
| Exit | THESEUS PHARMACEUTICALS INC | $0 | – | -1,400,352 | -100.0% | -0.28% | – | |
| Exit | ACELYRIN INC | $0 | – | -650,000 | -100.0% | -0.29% | – | |
| INSM | Exit | INSMED INC | $0 | – | -658,546 | -100.0% | -0.30% | – |
| Exit | MINERALYS THERAPEUTICS INC | $0 | – | -837,000 | -100.0% | -0.30% | – | |
| Exit | INVITAE CORPnote 2.000% 9/0 | $0 | – | -17,211,000 | -100.0% | -0.33% | – | |
| Exit | DA32 LIFE SCNCE TEC ACQSTN C | $0 | – | -1,600,000 | -100.0% | -0.35% | – | |
| TERN | Exit | TERNS PHARMACEUTICALS INC | $0 | – | -1,898,743 | -100.0% | -0.36% | – |
| Exit | VENTYX BIOSCIENCES INC | $0 | – | -617,000 | -100.0% | -0.43% | – | |
| ATEC | Exit | ALPHATEC HLDGS INC | $0 | – | -1,189,648 | -100.0% | -0.46% | – |
| Exit | XERIS BIOPHARMA HOLDINGS INCnote 5.000% 7/1 | $0 | – | -18,000,000 | -100.0% | -0.46% | – | |
| Exit | AMYLYX PHARMACEUTICALS INC | $0 | – | -1,050,198 | -100.0% | -0.48% | – | |
| APLS | Exit | APELLIS PHARMACEUTICALS INC | $0 | – | -313,289 | -100.0% | -0.61% | – |
| Exit | NEWAMSTERDAM PHARMA COMPANYordinary shares | $0 | – | -2,535,723 | -100.0% | -0.64% | – | |
| SILK | Exit | SILK RD MED INC | $0 | – | -1,132,229 | -100.0% | -0.78% | – |
| Exit | GUARDANT HEALTH INCnote 11/1 | $0 | – | -89,036,000 | -100.0% | -1.36% | – | |
| Exit | IONIS PHARMACEUTICALS INCnote 4/0 | $0 | – | -127,800,000 | -100.0% | -2.58% | – | |
| AMED | Exit | AMEDISYS INC | $0 | – | -1,794,000 | -100.0% | -3.50% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AERIE PHARMACEUTICALS INC | 36 | Q3 2022 | 3.6% |
| CENTENE CORP DEL | 30 | Q3 2023 | 3.0% |
| BIOCRYST PHARMACEUTICALS INC | 29 | Q3 2023 | 2.2% |
| MOLINA HEALTHCARE INC | 26 | Q3 2022 | 1.7% |
| EHEALTH INC | 25 | Q3 2020 | 2.0% |
| INTERCEPT PHARMACEUTICALS IN | 24 | Q1 2023 | 2.2% |
| MYLAN NV | 23 | Q3 2020 | 6.2% |
| PORTOLA PHARMACEUTICALS INC | 23 | Q1 2019 | 6.0% |
| BROOKDALE SR LIVING INC | 23 | Q3 2023 | 2.2% |
| ALIMERA SCIENCES INC | 23 | Q3 2019 | 0.8% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| DA32 Life Science Tech Acquisition Corp. | August 01, 2023 | 5,145,000 | 91.1% |
| CareMax, Inc. | March 13, 2023 | 18,691,423 | 16.4% |
| CareMax, Inc. | June 02, 2022 | 18,691,423 | 20.7% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3 | 2024-03-19 |
| 4 | 2024-03-19 |
| 4 | 2024-03-12 |
| 3 | 2024-03-08 |
| 4 | 2024-02-16 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-08 |
| 3 | 2024-02-01 |
| 4 | 2023-11-21 |
| 13F-HR | 2023-11-14 |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.